Plumb Pharmaceuticals, Inc. is a pioneering biotech company committed to revolutionizing medication compliance through its Extended Release Drug Delivery system. Founded in 2010, the company has made significant strides in the Biotechnology, Health Care, and Pharmaceutical industries. The company's proprietary Advanced Quantload (AQL™) technology is designed to extend drug release rates to months, presenting a groundbreaking solution for sustained therapeutic effects. This innovation has the potential to enable a single injection to deliver an entire course of antibiotics or provide continuous relief from chronic pain and addiction. Recently, on 18 April 2024, Plumb Pharmaceuticals, Inc. secured a $100.00K investment in a Seed Round from gener8tor, a significant milestone for the company's growth trajectory. This investment signifies the recognition and support from a reputable investor in the healthcare and biotech sector. With its innovative technology and strategic investment, Plumb Pharmaceuticals, Inc. is positioning itself as a formidable player in revolutionizing drug delivery and enhancing treatment outcomes.
No recent news or press coverage available for Plumb Pharmaceuticals, Inc..